Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 48 device-driven procedures, CMS 2024
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 22 | 2,281−6.3%/yr | −6.3%/yr | 4.70.7× | 43% | 2,570 in 2030+2%/yr |
| Dialysis access |
How the numbers are made · Every state · Compare two markets
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
| 25 |
| 1,806−14%/yr |
| −14%/yr |
| 4.10.7× |
| 13% |
| 1,510 in 2030−3%/yr |
| Superficial venous ablation | 10 | 988−4.4%/yr | −4.4%/yr | 2.00.3× | 83% | 1,300 in 2030+4.7%/yr |
| Carotid revascularization | 15 | 796−5.1%/yr | −5.1%/yr | 1.71.3× | 0% | 760 in 2030−0.8%/yr |
| Thrombectomy, IVC filters & venous stents | 3 | 595+3.1%/yr | +3.1%/yr | 1.30.8× | 5% | 810 in 2030+5.2%/yr |
| Aortic endografts (EVAR/TEVAR) | 2 | 285−10%/yr | −10%/yr | 0.61.3× | 0% | 280 in 2030−0.3%/yr |
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.